Circulating calprotectin levels four months after severe and non-severe COVID-19

BACKGROUND: Calprotectin is an inflammatory marker mainly released by activated neutrophils that is increased in acute severe COVID-19. After initial recovery, some patients have persistent respiratory impairment with reduced diffusion capacity of the lungs for carbon monoxide (DLCO) months after in...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Hussein, N., Machahua, C., Ruchti, SC., Horn, MP., Piquilloud, L., Prella, M., Geiser, TK., von Garnier, C., Funke-Chambour, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546778/
https://www.ncbi.nlm.nih.gov/pubmed/37789266
http://dx.doi.org/10.1186/s12879-023-08653-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546778/
https://www.ncbi.nlm.nih.gov/pubmed/37789266
http://dx.doi.org/10.1186/s12879-023-08653-7

Ejemplares similares